Hemorrhagic fever with renal syndrome and reversible splenial lesion syndrome ============================================================================= * Xulei Zhang * Yimin Ma * Renchen Cai * Zhenguo Qiao ## Abstract Hemorrhagic fever with renal syndrome (HFRS) and reversible splenial lesion syndrome are both considered uncommon conditions relatively rare. Fever, hemorrhage, and acute kidney injury are the prevailing symptoms frequently observed in cases of HFRS. We describe a case of a middle-aged man who had been hospitalized with fever and acute neurological symptoms. His main symptom was recurrent dizziness. Cranial computed tomography (CT) did not reveal any obvious lesions, such as encephalorrhagia or infarctions. The splenium of corpus callosum showed hyperintensity on brain magnetic resonance imaging (MRI), which is in line with the characteristic radiographic observations of reversible splenial lesion syndrome (RESLES). Further analyses revealed that the patient’s platelet counts had decreased to 7×109/L while hemorrhagic fever antibodies were positive. Eventually, the patient was diagnosed with HFRS and exhibited clinical improvements after active treatment. **H**emorrhagic fever with renal syndrome is an acute zoonotic infectious disease caused by Hantavirus genera within the Bunyaviridae family. Hantan virus (HTNV) and the Seoul virus (SEOV) are the predominant causative agents of HFRS in China. The illness is characterized by symptoms such as fever, hemorrhage and renal impairments.1,2 In some hemorrhagic fever patients, the early symptoms are atypical, with higher rates of missed diagnosis and misdiagnosis. In this case, we describe a case of patient diagnosed with HFRS coupled with reversible splenial lesion syndrome (RESLES). ## Case Report Patient information. A 58-year-old male patient arrived at out facility with a fever and dizziness 3 days. On the preceding day, the symptoms worsened, accompanied by slurred speech, muscle weakness with instability, and difficulty in walking. The patient denied having any prior medical conditions such as hypertension, dyslipidemia, epilepsia, or a history of smoking, alcohol consumption, or illicit drug use. ### Clinical findings The patient’s blood pressure levels was measured at 121/85 mmHg, which falls within a normal range. Additionally, the neurological examination yielded normal results. Initial serum testing revealed normal white blood cell, apart from mild reductions in platelet counts (reference range: 100-300 mmol/L) and reduced potassium levels (3.07; reference range: 3.6-5.5 mmol/L). The IgG and IgM antibodies against epidemic Influenza A and B virus as well as hemorrhagic fever virus were negative. CSF detection and computed tomography (CT) of the head was normal. ### Diagnostic assessment Due to the neurological symptoms, the possibility of acute cerebral infarction was considered. The next day, the patient was hospitalized at the neurology department. After hospitalization, his symptoms were progressive, including high fever (heat peak of 39.5°C),significant fatigue, shortness of breath, and depressed spirit. Brain magnetic resonance imaging (MRI) showed areas of high-signal-intensity on T2WI, FLAIR, and DWI (**Figure 1 A-E**). The observed hyperintensity in the splenium of the corpus callosum corresponded with the characteristic radiographic findings associated with RESLES. Procalcitonin levels were increased to 30.41 ng/ml, while his platelet counts were significantly decreased to 7.0*109/L (**Table 1**). Re-examination of hemorrhagic fever antibodies revealed positive outcomes. Therefore, his diagnosis was confirmed as hemorrhagic fever virus infection complicated with reversible splenial lesion syndrome. ![Figure 1](http://nsj.org.sa/https://nsj.org.sa/content/nsj/28/4/270/F1.medium.gif) [Figure 1](http://nsj.org.sa/content/28/4/270/F1) Figure 1 - On the day of admission, MRI (a-e) showed areas of high-signal-intensity on T2WI, FLAIR, and DWI. And after effective treatments, follow-up MRI (f-j) revealed significant regression of the lesion in SCC. View this table: [Table 1](http://nsj.org.sa/content/28/4/270/T1) Table 1 - Abnormal indicators of peripheral blood analysis. ### Therapeutic assessment Considering the suspected cause of his condition and the results of laboratory tests, the patient received a comprehensive treatment regimen that included acyclovir, antibiotics, blood transfusion, and correction of electrolyte imbalance among other treatments. ### Follow-up and outcomes The patient experienced a rapid improvement in clinical symptoms, leading to his discharge on the 20th day after onset. Approximately 1 month after being discharged, the patient returned to the hospital’s outpatient clinic for follow-up examination, which included a repeat of MRI. The MRI resuts revealed the complete resolution of the initial lesion (**Table 2**, **Figure 1 F-J**). View this table: [Table 2](http://nsj.org.sa/content/28/4/270/T2) Table 2 - Timeline table. ## Discussion We present a case of hemorrhagic fever highlighting typical imaging findings suggesting RESLES. This patient lacked a typical presentation of hemorrhagic fever at the first visit, except fever. Hemorrhagic fever with renal syndrome (HFRS) is a natural focus disease caused by Hantavirus infections. This condition has been observed to cause diffuse damage to micro-vessels throughout the body, destruction of vascular endothelial cells, increased permeability of capillaries and a decrease in platelet counts.3 Human infections with Hantaviruses majorly occur through contact with rodent excreta, including urine, feces, or saliva harboring the virus.4 In the present case, although he denied being bitten by mice, it is possible that he unknowingly came into contact with objects contaminated by virus. Acute kidney injury, increased vascular permeability, and coagulation abnormalities are typical manifestations during viral hemorrhagic fevers. The enhanced state of inflammation caused by hantavirus infections contributes to increased risk of stroke during acute HFRS. This patient had no typical presentations of hemorrhagic fevers at the first visit, except fever. Reversible splenial lesion syndrome (RESLES) is an extremely uncommon clinical condition, and its precise cause remains unknown. Among the known causes of RESLES, the most common ones include infections, epilepsy, high-altitude cerebral oedema, as well as nutritional and metabolic factors including hypoglycaemia and hypernatraemia, systemic lupus erythematosus etc.,5 Incidences of RESLES are closely associated with infections, particularly viral infections, such as measles, herpes virus,6 Epstein-Barr virus, dengue virus, varicella-zoster virus, and adenovirus.6 The RELES has diverse clinical features, including headaches, seizures, loss of consciousness, mental abnormalities, dizziness, obtundation and syncope.7,8 Most patients have good prognostic outcomes. In our case, the patient was admitted to the hospital with symptoms of dizziness and fever, with increased levels of inflammatory indicators. The increase in inflammatory factors and inflammatory cells led to cytotoxic oedema, suggesting that RESLES stimulates the immune system and can increase the levels of a few inflammatory response factors. Based on these findings, the author postulates that HFRS is a potential trigger factor for RESLES. This rare case brings attention the occurrence of RESLES as an atypical neurological manifestations of HFRS. However, additional large-scale studies are necessary to verify the RESLES-associated morbidity rates in HFRS patients. When patients present with fever and neurological symptoms, clinicians should consider HFRS, repeatedly check the hemorrhagic fever antibodies, and perform blood routine analyses to avoid treatment delay. ## Acknowledgement *The authors gratefully acknowledge easy editing Ltd. for the English language editing.* * Received April 9, 2023. * Accepted July 31, 2023. * Copyright: © Neurosciences Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. ## References 1. 1.Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev 2010; 23: 412–441. [Abstract/FREE Full Text](http://nsj.org.sa/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiY21yIjtzOjU6InJlc2lkIjtzOjg6IjIzLzIvNDEyIjtzOjQ6ImF0b20iO3M6MTg6Ii9uc2ovMjgvNC8yNzAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 2. 2.Zhang YZ, Zou Y, Fu ZF, Plyusnin A. Hantavirus infections in humans and animals, China. Emerg Infect Dis 2010; 16: 1195–1203. [CrossRef](http://nsj.org.sa/lookup/external-ref?access_num=10.3201/eid1608.090470&link_type=DOI) [PubMed](http://nsj.org.sa/lookup/external-ref?access_num=20678311&link_type=MED&atom=%2Fnsj%2F28%2F4%2F270.atom) [Web of Science](http://nsj.org.sa/lookup/external-ref?access_num=000280452600001&link_type=ISI) 3. 3.Sundberg E, Hultdin J, Nilsson S, Ahlm C. Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness. PLoS One 2011; 6: e21134. [CrossRef](http://nsj.org.sa/lookup/external-ref?access_num=10.1371/journal.pone.0021134&link_type=DOI) [PubMed](http://nsj.org.sa/lookup/external-ref?access_num=21731657&link_type=MED&atom=%2Fnsj%2F28%2F4%2F270.atom) 4. 4.Rista E, Pilaca A, Akshija I, Rama A, Harja E, Puca E, et al. Hemorrhagic fever with renal syndrome in Albania. Focus on predictors of acute kidney injury in HFRS. J Clin Virol 2017; 91: 25–30. 5. 5.Canas AV, Torrealba RG, Villar NR. Clinical spectrum of callosum corpus splenium lesions: subdiagnostics of a common entity. J Neurol Stroke 2018; 8: 74–78. 6. 6.Gao X, Feng Q, Arif S, Liaqat J, Li B, Jiang K. Clinical analysis of reversible splenial lesion syndrome in Chinese adults: A retrospective study of 11 cases. Medicine (Baltimore) 2020; 99: e22052. 7. 7.Chen WX, Liu HS, Yang SD, Zeng SH, Gao YY, Du ZH, et al. Reversible splenial lesion syndrome in children: retrospective study and summary of case series. Brain Dev 2016; 38: 915–927. [CrossRef](http://nsj.org.sa/lookup/external-ref?access_num=10.1016/j.braindev.2016.04.011&link_type=DOI) [PubMed](http://nsj.org.sa/lookup/external-ref?access_num=27591118&link_type=MED&atom=%2Fnsj%2F28%2F4%2F270.atom) 8. 8.Zhang S, Ma Y, Feng J. Clinicoradiological spectrum of reversible splenial lesion syndrome (RESLES) in adults: a retrospective study of a rare entity. Medicine (Baltimore) 2015; 94: e512.